Pelthos Therapeutics Inc.
PTHS· NYSE
Released Mar 19, 2026, before the open
10-K filed Mar 19, 2026, 78 days after period end · 0001919246-26-000013
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|
| Revenue | $9.39M | — | — |
| Net Income | -$21.66M | -$1.93M | -$4.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pelthos Therapeutics Inc. · CIK 1919246 · Engraved from SEC EDGAR